Treatment with α-melanocyte-stimulating hormone (α-MSH; 150 nM) increased the melanin content of melanoma cells as well as the expression of melanogenic proteins, namely MITF, TYR, and TRP-1,2 compared with that in the negative control (p < 0.05; Figure 4B,C). The gene discussed is STAMBP; the disease is melanoma.